Biomedical subjects
Publications and source records attributed to J Paul.
Explore the source record for details and available documents.
An attempt has been made to construct an assay potentially suitable for use with primary cultures of human tumours to measure the survival of exponentially growing monolayer cultures after exposure to anti-neoplastic drugs. Cell survival was assessed using their protein synthetic capacity after removal of drugs. HeLa cells were employed to avoid the ingerent variability and heterogeneity of primary cultures from human tumours, and an assay has been constructed using microtitration trays to provide large numbers of replicate cultures without the requirement of a large number cells. An increase in the duration of the exposure to drug increased sensitivity in nearly all cases examined. Similarly, an increase in the period of culture following drug removal produced increased sensitivity to alkylating agents but allowed recovery from exposure to certain cycle-dependent drugs. Some of the drugs used were shown to be unstable under culture conditions and vinblastine was actively metabolized, although this instability was not necessarily reflected in the time course of the drug's effect. Mustine sensitivity was shown to be reduced by an increase in cell density at a level where density limitation of 3H-thymidine incorporation becomes apparent. These variations and possible methods of minimizing their effects are discussed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Iron incorporation (59Fe) into erythropoietic cells from adult and foetal (11- to 15-day) peripheral blood and from foetal (12- to 15-day) livers has been investigated. Ion-exchange chromatography of haemolysates from such cells revealed two groups of 59Fe-containing proteins. The first group (X-fraction) was eluted from CMC-columns in the void volume and was highest in lysates of immature erythropoietic cells. This fraction contained a radiolabelled haemprotein of high molecular weight as well as other 59Fe-containing proteins. The haemprotein does not appear to be related to haemoglobin. The second group consisted of haemoglobins. One major (A1) and two minor (A2 and A3) haemoglobins were found in adult peripheral blood. In foetal liver lysates two major (F1 and A1) and two minor (F2 and A3) haemoglobins were present. The relative proportion of the major haemoglobins changed during development. Haemoglobin F1 was highest in the more mature livers. F1 proved to be different from A1 by chromatographic behaviour, in polypeptide chain composition and in fingerprints. A unique foetal polypeptide chain, intermediate in electrophoretic behaviour between the adult alpha- and beta-chain, was identified. In young foetal peripheral blood (11-day), in which 95% of the cells are of yolk-sac origin, one major (E1), two intermediate (E2 and E3) and one minor (F1) haemoglobin were demonstrable. Haemolysates of the peripheral blood of older embryos contain haemoglobins from erythroid cells of both yolk-sac and foetal liver origin. The haemoglobin pattern of such lysates is explicable in terms of the decreasing amount of embryonic haemoglobins (E1, E2 and E3) and the increasing amount of foetal haemoglobins (F1 and A1). Since A1 and E1 are the most prominent haemoglobins of livers from young embryos and yolk-sac erythrocytes respectively, and since they are very similar in chromatographic behaviour, foetal peripheral blood at all stages contain one dominant haemoglobin peak in the A1-E1 region. Most authors have neglected the relatively slight elevation of the foetal haemoglobin peak (F1) in front of A1-E1, the more because the F1-A1 region has been suspected sometimes to contain artificial haemoglobin components (Riggs, 1965). This probably explains why no foetal haemoglobin (F1) has been reported previously in the peripheral blood of foetal mice.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Globin mRNA levels in 11-15-day mouse fetal liver cells have been estimated by in situ hybridization of a highly labeled DNA copy (cDNA) of adult globin messenger RNAs (mRNAs) (globin cDNA) to fixed preparations of cells. Under the conditions employed, no significant in situ hybridization occurred to lymphoma cells (L 51787), mouse L cells, or hepatocytes; whereas reticulocytes from phenyl hydrazine-treated mice showed extensive in situ hybridization. The proportion of fetal liver cells showing predominantly cytoplasmic in situ hybridization increased from about 30% at the 11th day of development to 80-85% by days 13-15. Unlike more mature cells, proerythroblasts did not show in situ hybridization, except to a slight extent at later stages of development. These studies therefore indicate that globin mRNAs begin to accumulate during or shortly after the proerythroblastbasophilic erythroblast transition. The fact that certain immature erythroid cells from 14-day fetal liver contain substantial amounts of globin mRNAs has been confirmed by comparing the hybridization in solution of globin cDNA to cytoplasmic RNA extracted from total fetal liver cells or from immature erythroid cells obtained by treatment of fetal liver cells with an antiserum raised against erythrocytes.
Globin messenger RNA (mRNA) levels in Friend virus-transformed mouse cells have been estimated by in situ hybridization of DNA copy (cDNA) to fixed preparations of cells and by hybridization of cDNA to extracted cytoplasmic RNA in true solution. The results obtained by both methods agree in showing that a low level of globin mRNA can be detected in untreated Friend cells. The levels of hemoglobin and globin mRNA have also been correlated after treatment of Friend cells with dimethyl sulfoxide (DMSO). The results obtained by both experimental approaches show that there is a minimum period of treatment with DMSO required in order that Friend cells may become hemoglobinized, and that this period coincides with the time when globin mRNA accumulates. Moreover, bromodeoxyuridine prevents both hemoglobin and globin mRNA accumulation.